Clinical TrialsSearch results
Number of results: 386
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Dose-intensive weekly combination chemotherapy (cisplatin, vincristine, doxorubicin and etoposide) followed by cisplatin-etoposide therapy with concurrent thoracic irradiation: evaluation of a new treatment for limited-disease small-cell lung cancer.
- limited-disease small-cell lung cancer
- West Japan Oncology Group
- 2005-09-09
Other
- randomized study of Gemicitabine alone or UFT adjuvant chemotherapy for stage IB-IIIA non small cell lung cancer after complete resection
- stage IB-IIIA non small cell lung cancer after complete resection
- West Japan Oncology Group
- 2005-09-06
Other
- Effects of modifications of CKD care systems at general practice physicians on cooperation with nephrologists and outcome of CKD patients.
- chronic kidney disease
- University of Tsukuba
- 2008-05-16
Other
- Discontinuation of infliximab therapy after acquisition of low disease activity by infliximab in rheumatoid arthritis study: RRR (remission induction by remicade) study
- rheumatoid arthritis
- University of Occupational & Environmental Health, Japan
- 2009-06-23
Completed
- Multicenter interventional study of pain relief effect of Epicil during radiotherapy for head and neck cancer
- Head and neck cancer
- Umeda Masahiro
- 2019-03-13
Completed
- Usefulness of GC RELINE II for maxillofacial prosthesis patient
- Maxillary defect
- Umeda Masahiro
- 2019-09-26
Completed
- Usefulness of Semi-fixed oral appliance for obstructive sleep apnea patients
- obstructive sleep apnea
- Umeda Masahiro
- 2019-09-06
Completed
- Usefulness of Tetracycline ointment for open wound of the jawbone
- Tumor or cyst of jaw bone
- Umeda Masahiro
- 2019-09-03
Recruiting
- Nitrous oxide inhalation sedation/analgesia for strabismus surgery
- Strabismus
- Uematsu Masafumi
- 2024-12-27
Other
- Phase I/II Study to Evaluate the Safety and Efficacy of JB-101(Induced T Cell With Suppressing Functions), to Induce Operational Tolerance in Living Donor Liver Transplantation.
- Patients with end-stage liver failure undergoing living-donor liver transplantation.
- Uchida Koichiro
- 2020-12-17